Carregando...

From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research

Treatment of Myasthenia Gravis (MG) is still based on non-specific immunosuppression. Long-term high dose corticosteroids is still a major cause of side effects, in young as well as in elderly patients in whom comorbidities further increase the burden of chronic immunosuppression. Moreover, awarenes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Renato Mantegazza, Carlo Antozzi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020-09-01
coleção:Frontiers in Neurology
Assuntos:
Acesso em linha:https://www.frontiersin.org/article/10.3389/fneur.2020.00981/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!